CD8A and lung adenocarcinoma: Furthermore, we demonstrated that using sEVs as a delivery system to knock down LINC01711 could successfully enhance the infiltration of CD8+ T cells within the tumor, providing a novel approach to sensitize lung adenocarcinoma to immunotherapy.